Abu Dhabi becomes first location to receive anti-Covid-19 medication

Abu Dhabi becomes first location to receive anti-Covid-19 medication

The anti-viral treatment for Covid-19, Sotrovimab, is now available for early treatment of certain categories of patients in the UAE. The availability of the medicine follows an agreement between the Abu Dhabi Department of Health, the country's group purchasing organization (GPO) Rafed, and biopharmaceutical company GlaxoSmithKline (GSK). Etihad Cargo, the cargo and logistics arm of the Etihad Aviation Group and Hope Consortium, have transported the first batch of Sotrovimab into the UAE utilising its IATA CEIV-certified PharmaLife product. With the arrival of the first shipment at the Abu Dhabi airport, the capital emirate become the first location globally to receive this drug, reported. Sotrovimab is a monoclonal antibody treatment delivered through intravenous therapy, and can be used to treat adults and children above the age of 12 who meet certain criteria and are at risk of progressing to a severe Covid-19 condition, as per protocols that have been developed by the National Scientific Committee. Studies reveal that the medicine has proven to prevent hospitalisation and death in 85 per cent of early selected treatment cases and can work on all known variations to date. The National Scientific Committee in the country's health ministry and Abu Dhabi Department of Health have